Evolus (EOLS) EBT (2017 - 2026)
Evolus' (EOLS) quarterly EBT came in at -$10.4 million in Q1 2026, up 44.64% YoY from -$7.2 million in Q1 2025, and down 2122.91% on a QoQ basis from $515000.0 in Q4 2025.
Evolus (EOLS) EBT (2017 - 2026) Analysis & Trends
Evolus (EOLS) has 10 years of EBT data on file, last reported at -$10.4 million in Q1 2026.
- Quarterly EBT rose 44.64% year-over-year to -$10.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$42.6 million (up 23.33% YoY) and the FY2025 annual result came in at -$51.0 million, down 2.43% from the prior year.
- EBT retreated to -$10.4 million in Q1 2026, from $515000.0 in the prior quarter.
- In the past five years, EBT ranged from a high of $515000.0 in Q4 2025 to a low of -$23.4 million in Q2 2022.
- A 5-year average of -$14.5 million and a median of -$15.6 million in 2025 frame the typical range for EBT.
- Annual changes were most pronounced in 2022 — EBT plunged 372.93% — and 2025, when it surged 108.11%.
- Tracing EOLS's EBT over 5 years: stood at -$13.1 million in 2022, then grew by 10.54% to -$11.7 million in 2023, then soared by 45.83% to -$6.4 million in 2024, then surged by 108.11% to $515000.0 in 2025, then sank by 2122.91% to -$10.4 million in 2026.
- The last three EBT figures came in at -$10.4 million (Q1 2026), $515000.0 (Q4 2025), and -$15.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | -455.00 Mn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 372.70 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -64.00 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 162.20 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 56.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Evolus | 554.79 Mn | 509.62 Mn | 57.18 Mn | -8.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -8.21 Mn |
| Mar 31, 2026 | -10.42 Mn |
| Dec 31, 2025 | 515,000.00 |
| Sep 30, 2025 | -15.57 Mn |
| Jun 30, 2025 | -17.09 Mn |
| Mar 31, 2025 | -18.82 Mn |
| Dec 31, 2024 | -6.35 Mn |
| Sep 30, 2024 | -19.04 Mn |
| Jun 30, 2024 | -11.31 Mn |
| Mar 31, 2024 | -13.06 Mn |
| Dec 31, 2023 | -11.73 Mn |
| Sep 30, 2023 | -16.90 Mn |
| Jun 30, 2023 | -18.12 Mn |
| Mar 31, 2023 | -14.77 Mn |
| Dec 31, 2022 | -13.11 Mn |
| Sep 30, 2022 | -20.26 Mn |
| Jun 30, 2022 | -23.44 Mn |
| Mar 31, 2022 | -17.50 Mn |
| Dec 31, 2021 | -18.17 Mn |
| Sep 30, 2021 | -19.42 Mn |